• Home

  • Documents

  • · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 —...
22

· PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)

Embed Size (px)

Citation preview

Page 1: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 2: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 3: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 4: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 5: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 6: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 7: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 8: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 9: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 10: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 11: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 12: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 13: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 14: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 15: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 16: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 17: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 18: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 19: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 20: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 21: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)
Page 22: · PDF fileMicro-nanosisteme pentru aplicatii biomedicale BIO-MEMS ... 1 100 ng/mL (2 — 6 ng/mL valori ... 30 minute 16 h PotentlaI(mV)

Human Prostate Cells Synthesize 1,25-Dihydroxyvitamin D3 ... · ng/ml), insulin (5 g/ml), and prostaglandin E1 (50 ng/ml). To enhance the plating efficiency, 0.1 g/ml cholera toxin

Human Prostate Cells Synthesize 1,25-Dihydroxyvitamin D3 ... · ng/ml), insulin (5 g/ml), and prostaglandin E1 (50 ng/ml). To enhance the plating efficiency, 0.1 g/ml cholera toxin

Documents
Dímero D en el Registro Informatizado de pacientes con … · BNP > 90 pg/ml / NT- proBNP > 600 pg/ml Troponina > 0,1 ng/ml Dímero D > 5000 ng/ml. ESTRATIFICACION DE RIESGO EN TEP

Dímero D en el Registro Informatizado de pacientes con … · BNP > 90 pg/ml / NT- proBNP > 600 pg/ml Troponina > 0,1 ng/ml Dímero D > 5000 ng/ml. ESTRATIFICACION DE RIESGO EN TEP

Documents
Mean Plasma Concentration (SD) at Steady State (ng/mL)

Mean Plasma Concentration (SD) at Steady State (ng/mL)

Documents
Ganglioside GM1 theTrk receptor - PNAScontrol, 0; NGF(1 ng/ml), 1 ± 0.3; NGF(50ng/ml), 33 ± 2.7; NGF(1 ng/ml) +GM1,46 + 3.1; NGF(50ng/ml) +GM1,78 ±4.3; andGM1 alone, 0 (mean ±

Ganglioside GM1 theTrk receptor - PNAScontrol, 0; NGF(1 ng/ml), 1 ± 0.3; NGF(50ng/ml), 33 ± 2.7; NGF(1 ng/ml) +GM1,46 + 3.1; NGF(50ng/ml) +GM1,78 ±4.3; andGM1 alone, 0 (mean ±

Documents
Radiofrequency Ablation Combined with Chemoembolization ...€¦ · 20-200 ng/mL 7 (33.3%) > 200 ng/mL 2 (9.5%) Note.— HCC = hepatocellular carcinoma, AFP = alpha fetoprotein. 250

Radiofrequency Ablation Combined with Chemoembolization ...€¦ · 20-200 ng/mL 7 (33.3%) > 200 ng/mL 2 (9.5%) Note.— HCC = hepatocellular carcinoma, AFP = alpha fetoprotein. 250

Documents
Heregulin 50 ng/ml

Heregulin 50 ng/ml

Documents
Bioanalytical Assay List (Mass Spectrometry)...LC/MS/MS 10-8000 ng/mL; 25-20000 ng/mL Human Urine Miscellaneous 2-Pyridylacetic Acid LC/MS/MS 2-1000 ng/mL Human EDTA Plasma Miscellaneous

Bioanalytical Assay List (Mass Spectrometry)...LC/MS/MS 10-8000 ng/mL; 25-20000 ng/mL Human Urine Miscellaneous 2-Pyridylacetic Acid LC/MS/MS 2-1000 ng/mL Human EDTA Plasma Miscellaneous

Documents
Asociación Bioquímica de Mendoza - TUMOR …...testosterona hombre 20-40 años vr: 2,49-8,36 ng/ml. 0,03 ng/ml h´ myor de 50 años: 1,93-7,40 ng/ml. amar claro amarillo amar claro

Asociación Bioquímica de Mendoza - TUMOR …...testosterona hombre 20-40 años vr: 2,49-8,36 ng/ml. 0,03 ng/ml h´ myor de 50 años: 1,93-7,40 ng/ml. amar claro amarillo amar claro

Documents
Solving Poison Control Center Intoxication Cases Using ... · MDA MDE Serum, 2/20 87 ng/mL 18.82 ng/mL 61 ng/mL Serum, 2/26 ND ND ND Urine, 2/22 395 ng/mL 123.3 ng/mL 46 ng/mL Green

Solving Poison Control Center Intoxication Cases Using ... · MDA MDE Serum, 2/20 87 ng/mL 18.82 ng/mL 61 ng/mL Serum, 2/26 ND ND ND Urine, 2/22 395 ng/mL 123.3 ng/mL 46 ng/mL Green

Documents
Chimica Farmaceutica Biomedicale Web

Chimica Farmaceutica Biomedicale Web

Documents
SETTORE BIOMEDICALE Storie di Successo - iom.invensys.comiom.invensys.com/EN/SuccessStoriesIOM/dideco.pdf · SETTORE BIOMEDICALE Storie di Successo Sorin Group Italia - Dideco Mirandola

SETTORE BIOMEDICALE Storie di Successo - iom.invensys.comiom.invensys.com/EN/SuccessStoriesIOM/dideco.pdf · SETTORE BIOMEDICALE Storie di Successo Sorin Group Italia - Dideco Mirandola

Documents
Celuloza Cu Aplicatii Biomedicale

Celuloza Cu Aplicatii Biomedicale

Documents
The complement cascade - AbcamComplement C3a des Arg Hu Competitive Plasma 0.12 ng/ml 20 - 0.313 ng/ml ab133037 Complement C4 Hu Sandwich Serum, Plasma 0.3 µg/ml 5 - 0.313 µg/ml

The complement cascade - AbcamComplement C3a des Arg Hu Competitive Plasma 0.12 ng/ml 20 - 0.313 ng/ml ab133037 Complement C4 Hu Sandwich Serum, Plasma 0.3 µg/ml 5 - 0.313 µg/ml

Documents
Research Paper Development and Validation of a Serum ... · OD of 450 nm. For Intra-assay Precision: CHI3L1, CV: 5.2% (0.25 ng/ml) and CV: 3.6% (2 ng/ml); MMP13, 4.9% (2 ng/ml) and

Research Paper Development and Validation of a Serum ... · OD of 450 nm. For Intra-assay Precision: CHI3L1, CV: 5.2% (0.25 ng/ml) and CV: 3.6% (2 ng/ml); MMP13, 4.9% (2 ng/ml) and

Documents
TB28995-STEMdiff APEL Medium - STEMCELL Technologies · 2016-03-04 · STEMdiffTM APEL TM Medium supplemented with 300 ng/mL SCF, 300 ng/mL Flt-3 ligand, 10 ng/mL IL-3, 10 ng/mL IL-6,

TB28995-STEMdiff APEL Medium - STEMCELL Technologies · 2016-03-04 · STEMdiffTM APEL TM Medium supplemented with 300 ng/mL SCF, 300 ng/mL Flt-3 ligand, 10 ng/mL IL-3, 10 ng/mL IL-6,

Documents
Tumor and 3T3 - PNAS · diester %ofcells %ofcells %ofcells PMA 50 ng/ml 11 89 88 25 ng/ml 15 82 84 S ng/ml 48 60 61 PBz2 125 ng/ml 26 69 68 25 ng/ml 49 33 34 5 ng/ml 81 8 8 PAc2 125

Tumor and 3T3 - PNAS · diester %ofcells %ofcells %ofcells PMA 50 ng/ml 11 89 88 25 ng/ml 15 82 84 S ng/ml 48 60 61 PBz2 125 ng/ml 26 69 68 25 ng/ml 49 33 34 5 ng/ml 81 8 8 PAc2 125

Documents
Development of a UPLC-MS/MS Method for the Determination ......0.150/2.50 ng/mL 1.00/2.50 ng/mL 8.00/2.50 ng/mL % Recovery 80.3 86.6 87.5 Mean % Recovery 84.8 IS Normalized Matrix

Development of a UPLC-MS/MS Method for the Determination ......0.150/2.50 ng/mL 1.00/2.50 ng/mL 8.00/2.50 ng/mL % Recovery 80.3 86.6 87.5 Mean % Recovery 84.8 IS Normalized Matrix

Documents
INTRODUCTION INSTRUMENTATION BIOMEDICALE …...GÉNIE BIOMÉDICAL index INTRODUCTION INSTRUMENTATION BIOMEDICALE BUT D'APPLICATION DU LABORATOIRE: OBJECTIFS PROFIL DU COURS MANUELS

INTRODUCTION INSTRUMENTATION BIOMEDICALE …...GÉNIE BIOMÉDICAL index INTRODUCTION INSTRUMENTATION BIOMEDICALE BUT D'APPLICATION DU LABORATOIRE: OBJECTIFS PROFIL DU COURS MANUELS

Documents
Celuloza Si Dispozitive Biomedicale

Celuloza Si Dispozitive Biomedicale

Documents
Persistence and Toxin Production by Clostridium difficile within … · cin, and growth factors containing 100 ng/ml Noggin (6057-NG; R&D Systems), 100 ng/ml epidermal growth factor

Persistence and Toxin Production by Clostridium difficile within … · cin, and growth factors containing 100 ng/ml Noggin (6057-NG; R&D Systems), 100 ng/ml epidermal growth factor

Documents
Millenium Biomedicale Private Limited

Millenium Biomedicale Private Limited

Documents
HyperTonie Intra-Oculaire Cortico-Induitejournee-montpellieraine-ophtalmologie.fr/files/137/COMM/...50 mg per os prednisone 5 ng/ml 12 ng/ml 60 ng/ml 5 mg péribulbaire dexaméthasone

HyperTonie Intra-Oculaire Cortico-Induitejournee-montpellieraine-ophtalmologie.fr/files/137/COMM/...50 mg per os prednisone 5 ng/ml 12 ng/ml 60 ng/ml 5 mg péribulbaire dexaméthasone

Documents
Pachete de Modelare a Sistemelor Biomedicale

Pachete de Modelare a Sistemelor Biomedicale

Documents
Signal: Noise Approaches to Improve Sensitivity and Drug ... · 1000 ng/mL ADA2 4.87 1.9084 4.98 200 ng/mL ADA5 .616 1.1638 .847 100 ng/mL ADA4 .687 1.0344 .885 50 ng/mL ADA3 .561

Signal: Noise Approaches to Improve Sensitivity and Drug ... · 1000 ng/mL ADA2 4.87 1.9084 4.98 200 ng/mL ADA5 .616 1.1638 .847 100 ng/mL ADA4 .687 1.0344 .885 50 ng/mL ADA3 .561

Documents
Oral Fluid Drug Screen Device - Andatechdocuments.andatech.com.au/manuals/oratect-iii-saliva-drug-testing-k… · Diazepam 25 ng/ml 40 ng/ml 20 ng/ml 25 ng/ml 10 ng/ml 5 ng/ml 1

Oral Fluid Drug Screen Device - Andatechdocuments.andatech.com.au/manuals/oratect-iii-saliva-drug-testing-k… · Diazepam 25 ng/ml 40 ng/ml 20 ng/ml 25 ng/ml 10 ng/ml 5 ng/ml 1

Documents
University of Groningen The long road: the …...mM 2-mercaptoethanol, 0.3 mg/mL rHu Holo-Transferrin (Sigma, city country), 40 ng/ mL rHu IGF-1 (Sigma), 20 ng/mL SCF, 5 U/mL rHu EPO

University of Groningen The long road: the …...mM 2-mercaptoethanol, 0.3 mg/mL rHu Holo-Transferrin (Sigma, city country), 40 ng/ mL rHu IGF-1 (Sigma), 20 ng/mL SCF, 5 U/mL rHu EPO

Documents
Prof. Enzo Bonora · di patologia organica Testosterone >2 ng/ml →Tumore ovarico DHEAS >8 µg/ml →Tumore surrenalico 17-OH-progesterone >8 ng/ml →Iperplasia surrenalica 17-OH-progesterone

Prof. Enzo Bonora · di patologia organica Testosterone >2 ng/ml →Tumore ovarico DHEAS >8 µg/ml →Tumore surrenalico 17-OH-progesterone >8 ng/ml →Iperplasia surrenalica 17-OH-progesterone

Documents
CompostosAzólicosnaDoençade Chagas: situaçãoatual · AtividadeComparativa In vitro • Ravuconazol – MIC 300 nM(221 ng/ml) para formas epimastigotas – MIC 1 nM (7.4 ng/ml)

CompostosAzólicosnaDoençade Chagas: situaçãoatual · AtividadeComparativa In vitro • Ravuconazol – MIC 300 nM(221 ng/ml) para formas epimastigotas – MIC 1 nM (7.4 ng/ml)

Documents
9. Vitamine D et diabète - sfndt.org · PTH (pg/mL) 25OH D (ng/mL) P

9. Vitamine D et diabète - sfndt.org · PTH (pg/mL) 25OH D (ng/mL) P

Documents
ПРИЛОЖЕНИЕ I - ema.europa.eu...( 0,5 ng/ml) до 1,3 ng/ml. Тези концентрации са от 50 до 200-пъти по-ниски в сравнeние с концентрациите,

ПРИЛОЖЕНИЕ I - ema.europa.eu...( 0,5 ng/ml) до 1,3 ng/ml. Тези концентрации са от 50 до 200-пъти по-ниски в сравнeние с концентрациите,

Documents